Skip to main content
Log in

Arzneimittelreaktionen vom Soforttyp

Epidemiologie, Klinik, Auslöser und Management

Immediate drug hypersensitivity

Epidemiology, clinical features, triggers and management

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Arzneimittelüberempfindlichkeitsreaktionen betreffen über 7% der Bevölkerung und sind ein Problem für Patienten und Ärzte. Bei einem Teil solcher Reaktionen wurden IgE-vermittelte Mechanismen dokumentiert. Klinische Manifestationen von Reaktionen vom Soforttyp, die direkt nach Arzneimittelzufuhr (zumeist ≤1 h) auftreten, sind akute Urtikaria, Angioödem, Atemnot und andere Symptome der Anaphylaxie an Haut, Magen-Darm-Trakt, Atemwegen oder Kreislaufsystem. Arzneimittel führen in der überwiegenden Mehrzahl zu milderen Reaktionen, sind aber auch die häufigsten Auslöser fataler Anaphylaxien. Die mediane Dauer zwischen systemischer Zufuhr und klinischem Tod liegt dann bei etwa 5 min. Die wichtigsten auslösenden Arzneimittel sind Schmerzmittel, Antibiotika, Röntgenkontrastmittel und Muskelrelaxanzien. Ziel der anamnesegeleiteten Hauttestung und ggf. Labortestung ist der Nachweis einer Sensibilisierung, der in Abhängigkeit von dem auslösenden Arzneimittel nur bei weniger als der Hälfte der Fälle gelingt. Ansonsten ist häufig zur Klärung der Diagnose, d. h. zur Bestätigung oder zum Ausschluss einer Arzneimittelüberempfindlichkeit, eine Provokationstestung unter kontrollierten Bedingungen notwendig. Die Therapie besteht in der Meidung der auslösenden Arzneimittel, nur bei dringender Indikation wird eine Toleranzinduktion durch „Desensibilisierung“ durchgeführt.

Abstract

Drug hypersensitivity reactions affect more than seven percent of the population and are a concern for patients and doctors alike. In a substantial part of such reactions, IgE-mediated mechanisms have been documented. Clinical manifestations of immediate reactions, which occur directly after drug intake (mostly ≤ 1 h), are acute urticaria, angioedema, dyspnea and other symptoms of anaphylaxis in the skin, gastrointestinal tract, respiratory tract or cardiovascular system. Although normally leading to milder reactions, drugs are also the most frequent elicitors of fatal anaphylaxis. The median time interval between systemic drug application and clinical death is 5 min. The most common elicitors of immediate reactions are analgesics, antibiotics, radiocontrast media and muscle relaxants. The aim of history and experience guided skin tests ± laboratory tests is to document a sensitization, which depends on the eliciting drug and is only successful in less than half of the patients. Else a drug provocation test under controlled conditions is necessary to clarify the diagnosis and to confirm or exclude a drug hypersensitivity reaction. Therapy consists in drug avoidance or in pressing indications in tolerance induction by a “drug desensitization”.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Solensky R, Khan DA (2010) Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105:259–273

    Article  Google Scholar 

  2. Aberer W, Bircher A, Romano A et al (2003) Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 58:854–863

    Article  CAS  PubMed  Google Scholar 

  3. Bonadonna P, Lombardo C, Bortolami O et al (2012) Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test. J Allergy Clin Immunol 130:547–549

    Article  CAS  PubMed  Google Scholar 

  4. Brockow K, Bonadonna P (2012) Drug allergy in mast cell disease. Curr Opin Allergy Clin Immunol 12:354–360

    Article  CAS  PubMed  Google Scholar 

  5. Brockow K, Christiansen C, Kanny G et al (2005) Management of hypersensitivity reactions to iodinated contrast media. Allergy 60:150–158

    Article  CAS  PubMed  Google Scholar 

  6. Brockow K, Garvey LH, Aberer W et al (2013) Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 68:702–712

    Article  CAS  PubMed  Google Scholar 

  7. Brockow K, Przybilla B (2010) Arzneimittel-Überempfindlichkeiten. In: Ring J, Bachert C, Bauer CP, Czech W (Hrsg) Weißbuch Allergie in Deutschland. Urban & Vogel, München, S 182–190

  8. Brockow K, Ring J (2011) Anaphylaxis to radiographic contrast media. Curr Opin Allergy Clin Immunol 11:326–331

    Article  CAS  PubMed  Google Scholar 

  9. Brockow K, Romano A, Aberer W et al (2009) Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicenter study. Allergy 64:234–241

    Article  CAS  PubMed  Google Scholar 

  10. Brockow K, Romano A, Blanca M et al (2002) General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57:45–51

    CAS  PubMed  Google Scholar 

  11. Cernadas JR, Brockow K, Romano A et al (2010) General considerations on rapid desensitization for drug hypersensitivity – a consensus statement. Allergy 65:1357–1366

    Article  CAS  PubMed  Google Scholar 

  12. Chung CH, Mirakhur B, Chan E et al (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 358:1109–1117

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Demoly P, Adkinson NF Jr, Brockow K et al (2014) International Consensus (ICON) on drug allergy. Allergy 69:420–437

    Article  CAS  PubMed  Google Scholar 

  14. Garvey LH, Kroigaard M, Poulsen LK et al (2007) IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 120:409–415

    Article  CAS  PubMed  Google Scholar 

  15. Gomes ER, Demoly P (2005) Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 5:309–316

    Article  PubMed  Google Scholar 

  16. Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LA (2010) Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 125:1098–1104

    Article  PubMed  Google Scholar 

  17. Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C (2013) Diagnosis of penicil-lin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 68:1057–1064

    Article  CAS  PubMed  Google Scholar 

  18. Kowalski ML, Asero R, Bavbek S et al (2013) Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 68:1219–1232

    Article  CAS  PubMed  Google Scholar 

  19. Maggi E, Vultaggio A, Matucci A (2011) Acute infusion reactions induced by monoclonal antibody therapy. Expert Rev Clin Immunol 7:55–63

    Article  CAS  PubMed  Google Scholar 

  20. Mertes PM, Alla F, Trechot P et al (2011) Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 128:366–373

    Article  PubMed  Google Scholar 

  21. Mertes PM, Malinovsky JM, Jouffroy L et al (2011) Reducing the risk of anaphylaxis during anesthesia: 2011 up-dated guidelines for clinical practice. J Investig Allergol Clin Immunol 21:442–453

    CAS  PubMed  Google Scholar 

  22. Panesar SS, Javad S, Silva D de et al (2013) The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 68:1353–1361

    Article  CAS  PubMed  Google Scholar 

  23. Park CS, Kim TB, Kim SL et al (2008) The use of an electronic medical record system for mandatory reporting of drug hypersensitivity reactions has been shown to improve the management of patients in the university hospital in Korea. Pharmacoepidemiol Drug Saf 17:919–925

    Article  PubMed  Google Scholar 

  24. Pichler WJ (2006) Adverse side-effects to biological agents. Allergy 61:912–920

    Article  CAS  PubMed  Google Scholar 

  25. Przybilla B, Aberer W, Bircher AJ et al (2008) Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel. J Dtsch Dermatol Ges 6:240–243

    Article  PubMed  Google Scholar 

  26. Pumphrey RS (2000) Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30:1144–1150

    Article  CAS  PubMed  Google Scholar 

  27. Renaudin JM, Beaudouin E, Ponvert C et al (2013) Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy 68:929–937

    Article  CAS  PubMed  Google Scholar 

  28. Ribeiro-Vaz I, Marques J, Demoly P et al (2013) Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority. Eur J Clin Pharmacol 69:673–681

    Article  CAS  PubMed  Google Scholar 

  29. Ring J, Brockow K (2002) Adverse drug reactions: mechanisms and assessment. Eur Surg Res 34:170–175

    Article  CAS  PubMed  Google Scholar 

  30. Ring J, Franz R, Brockow K (2010) Anaphylactic reactions to local anesthetics. Chem Immunol Allergy 95:190–200

    Article  CAS  PubMed  Google Scholar 

  31. Thong BY, Tan TC (2011) Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 71:684–700

    Article  PubMed Central  PubMed  Google Scholar 

  32. Torres MJ, Blanca M, Fernandez J et al (2003) Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 58:961–972

    Article  CAS  PubMed  Google Scholar 

  33. Valent P, Akin C, Arock M et al (2012) Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 157:215–225

    Article  PubMed Central  PubMed  Google Scholar 

  34. Zirbs M, Seifert F, Zink A et al (2012) A shortened docetaxel desensitization protocol for use in special cases. J Eur Acad Dermatol Venereol 26:391–393

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. K. Brockow: Vortragstätigkeit für Thermo Fisher/Phadia. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Brockow.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brockow, K. Arzneimittelreaktionen vom Soforttyp. Hautarzt 65, 409–414 (2014). https://doi.org/10.1007/s00105-013-2695-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-013-2695-x

Schlüsselwörter

Keywords

Navigation